TP53 and central nervous system cancer: It is also important to report that, according to the TCGA dataset, TP53, PTEN, and CDKN2A alterations (mutation and deletion) are more prevalent in gliomas derived from astrocytic lineage, which confirms our results, since we found a significant association of these genes alterations with astrocytomas.